Active Shortage

MICAFUNGIN SODIUM FOR INJECTION

HIKMA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of MICAFUNGIN SODIUM FOR INJECTION in Canada?

Yes. MICAFUNGIN SODIUM FOR INJECTION 50MG has an active shortage reported to Health Canada (last updated April 26, 2025).

Why is MICAFUNGIN SODIUM FOR INJECTION not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will MICAFUNGIN SODIUM FOR INJECTION be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file1 product

Affected strength50MG

Report last updated2025-04-26

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

MICAFUNGIN SODIUM FOR INJECTION

JUNO PHARMACEUTICALS CORP.

50MG · DIN 02524953

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02532344

Strength

50MG

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS

Active Ingredient

MICAFUNGIN SODIUM

Tier

Unrated

Last Updated

2025-04-26

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from HIKMA CANADA LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

0.9% SODIUM CHLORIDE INJECTION USP

9MG · DIN 02304341

ACETYLCYSTEINE SOLUTION USP

200MG · DIN 02459906

ATROPINE INJECTION BP

0.6MG · DIN 02432196

ATROPINE INJECTION BP

0.4MG · DIN 02432188

AZACITIDINE FOR INJECTION

100MG · DIN 02507668

BACLOFEN INJECTION

0.05MG · DIN 02457059